EUVIMEDEUVIMED entdecken
Open Access

MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma

Xinjun Lu, Ya Zhang, Jiahao Xue, Matthias Evert, Diego Calvisi, Xin Chen iD, Xue Wang

Toxicological Sciences · 2025

DOI: 10.1093/toxsci/kfae126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Xinjun Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biliary-Pancreatic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Mad2 Proteins, Liver Neoplasms, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Guangdong Basic and Applied Basic Research Foundation, Science and Technology Program of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitotic arrest-deficient 2 like 1 (MAD2L1) is a component of the mitotic spindle assembly checkpoint implicated in cancer cell proliferation and tumorigenesis. The functional role of MAD2L1 in hepatocellular carcinoma (HCC) has not been adequately investigated, especially in vivo. In the current manuscript, we sought to address the function of MAD2L1 in hepatocarcinogenesis. We found that MAD2L1 expression is upregulated in human HCCs, where its expression is associated with higher aggressive tumor grade, elevated proliferative activity, and poor prognosis. In human HCC cell lines, MAD2L1 knockdown led to decreased cell growth. Moreover, RNA-seq results demonstrated that MAD2L1 silencing induces the expression of genes associated with cell cycle, DNA replication, and various cancer-related pathways, supporting the critical role of MAD2L1 during HCC growth and differentiation. In a c-MYC-induced mouse HCC model, we revealed an increased expression of Mad2l1. Furthermore, Mad2l1 CRIPSR-mediated silencing prevented c-MYC-driven mouse liver development. Altogether, our study suggests that MAD2L1 plays a crucial role in hepatocarcinogenesis, and that its suppression could be a promising therapeutic strategy for treating human HCC. MAD2L1 plays a critical role in liver cancer development, silencing MAD2L1 reduced cell growth in vitro and inhibited c-MYC-driven liver cancer development in vivo. MAD2L1 suppression might be a promising therapeutic approach for treating human liver cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularMad2 ProteinsLiver NeoplasmsProto-Oncogene Proteins c-mycAnimalsHumansMicePrognosisCell ProliferationCell Line, TumorMaleGene Expression Regulation, NeoplasticCarcinogenesisFemale

Stichwörter der Autor:innen

MAD2L1MYChepatocellular carcinoma

Substanzen

Mad2 ProteinsMAD2L1 protein, humanProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Department of Biliary-Pancreatic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
  • Cancer Biology Program, University of Hawai'i Cancer Center, University of Hawai'i, Honolulu, HA 96813, United States.
  • Institute of Pathology, University of Regensburg, Regensburg 93053, Germany.

ORCID-Profile: Xin Chen

Förderung

  • NCI NIH HHS
  • Guangdong Basic and Applied Basic Research Foundation
  • Science and Technology Program of Guangzhou
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Lu, X., Zhang, Y., Xue, J., Evert, M., Calvisi, D., Chen, X., & Wang, X. (2025). MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfae126

Vancouver

Lu X, Zhang Y, Xue J, Evert M, Calvisi D, Chen X, et al. MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfae126

BibTeX
@article{Lu2025,
  author = {Lu, Xinjun and Zhang, Ya and Xue, Jiahao and Evert, Matthias and Calvisi, Diego and Chen, Xin and Wang, Xue},
  title = {MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma},
  journal = {Toxicological Sciences},
  year = {2025},
  doi = {10.1093/toxsci/kfae126}
}
Kostenlos starten →